These awards provide up to £100,000 over two years and a personalised package of career support to help newly independent biomedical scientists to launch their research careers.

Key dates

Round 4 is now closed for applications. The Panel will convene in November.

Round 5 will launch in 2019.




Springboard offers a bespoke package of support to biomedical researchers at the start of their first independent post to help launch their research careers. This includes funding of up to £100,000 over two years and access to the Academy’s acclaimed mentoring and career development programme.

Find out more about our recent Springboard Award Holders Event.

About the scheme

In 2012, the Academy convened a Task Force, chaired by Professor Martin Humphries FMedSci, to examine ways for the Academy to further support early career researchers. Amongst other findings, the Task Force recommended the development of a funding scheme for non-clinical biomedical scientists.

Scoping work carried out by the Academy identified Lecturers, or equivalent, within the first three years of starting their post and who had not yet obtained significant funding as being in greatest need of support. The limited start-up packages normally provided and paucity of grant schemes available at this career stage makes establishing an independent research programme particularly challenging. 

In May 2015, the Academy partnered with the Wellcome Trust to initiate the Academy of Medical Sciences Springboard - a scheme to support biomedical researchers newly appointed to their first independent position. In 2017 we were delighted to welcome the British Heart Foundation and the Government Department of Business, Energy and Industrial Strategy, alongside the Wellcome Trust, to form a funding consortium for the scheme. For round 4, we warmly welcomed Diabetes UK joining the consortium. The scheme seeks to embrace the breadth of biomedical research and welcomes applications that contribute to the Academy’s mission to improve health through research.

Recent Awardees

Dr Shoba Amarnath, Newcastle University, The role of PD-1 in modulating ILC-2s in the tumour microenvironment

Dr Andrew Atkin, University of East Anglia, Age-related changes and determinants of physical activity, sedentary behaviour and sleep in young people

Dr Nicolas Barry, University of Bradford, Understanding the anticancer properties of metal-based drug candidates

Dr Akshay Bhinge, University of Exeter, Investigating the interactions of noncoding RNAs and aging pathways in driving motor neuron degeneration in ALS

Dr Lucy Bowes, University of Oxford, Adolescents at-risk of depression: examining the role of bullying as a causal risk factor using polygenic risk scores and virtual reality

Dr Ruth Bowness, University of St Andrews, Using individual-based mathematical models to study antibiotic resistance

Dr Jonathan Cox, Aston University, Investigating the physiology of non-replicating persistent mycobacteria for latent tuberculosis drug discovery

Dr Frank Dondelinger , University of Lancaster, Predicting clinical progression in biologically heterogeneous neurodegenerative diseases

Dr Maria Fragiadaki, University of Sheffield, Growth-hormone/STAT5 signalling in the polycystic kidney – using transcriptomics to unravel pathogenesis.

Dr Catherine  Grainger, University of Stirling, Remembering to remember: What techniques can be used to improve prospective memory in individuals with autism spectrum disorder (ASD)?

Dr James Hewitson, University of York, Do helminth-induced antibodies restrain macrophages in type-2 immunity?

Dr Michelle Holland, King's College London, Developmental programming of ribosomal DNA epigenetics: what is the functional link to metabolic disease risk?

Dr David Hughes, University of St Andrews, Posttranslational control of our innate immune response: exploring a novel role for ISGylation.

Dr Asif  Iqbal, University of Birmingham, Investigating the role of galectins in chronic inflammation associated with atherosclerosis

Dr Yi Jin, Cardiff University, A chemical biology approach to control sepsis

Dr Diana Jurk, Newcastle University, How does cell senescence impact on the ageing brain?

Dr Paul Kasher, University of Manchester, Identifying novel molecular regulators of brain injury following intracerebral haemorrhage

Dr Jemma Kerns, University of Lancaster, How does gene and protein expression, of collagen, affect the chemical and material properties of osteoarthritic bone?

Dr Matthew Loxham, University of Southampton, Redox Balance and Ferroptosis – A New Mechanism Behind the Health Effects of Air Pollution?

Dr MaryAnn Noonan, University of Oxford, The development of goal-directed behaviour and the underlying neural architecture across adolescence

Dr Linda Oude Griep , Imperial College London, A systems approach to reveal complex metabolic relations of fruit and vegetable consumption on cardiovascular health

Dr Catherine Pashley, University of Leicester, When biomes meet: Characterisation of bacterial and fungal microbiota in the airways of people with asthma and the impact of antimicrobial agents.

Dr Lavinia Paternoster, University of Bristol, Identification of drug targets for atopic dermatitis through multi-omic data integration

Dr Danielle Paul, University of Bristol, Cryo-Electron microscopy of cardiac thin filaments: Heart disease on a molecular level

Dr Elena Rainero, University of Sheffield, Unravelling extracellular matrix endocytosis in breast cancer

Dr Emma Robinson, King's College London, What makes your mind unique? Tailoring brain network models to individuals to enhance predictions of neurological development and disease

Dr Sebastian van de Linde, University of Strathclyde, Tuneable photoswitches for chromatic aberration-free multicolour super-resolution imaging

Dr Kirsty Wan, University of Exeter, Genesis and control of ciliary beating: a new look at an ancient structure

Dr Jun Wang, Queen Mary University of London, Characterisation of functional non-coding mutations in follicular lymphoma

Dr Sarah White, University College London, Strengths and weaknesses in non-verbal communication in autism

Dr Helge Wurdemann, University College London, Stiffness and position control for soft robotic devices suitable  for colo-rectal surgery

Dr Giulia Zanetti, University College London , Visualising the role of TANGO1 in COPII-mediated procollagen transport by cryo-EM

Dr Kate Baker, University of Liverpool, Multi-species models of antimicrobial resistance emergence and persistence, developed from real world epidemics.

Dr Marcella Bassetto, Cardiff University, Novel therapeutic strategies to overcome opsin misfolding and aggregation in retinal blinding diseases.

Dr Tim Blower, University of Durham, Regulating bacterial growth through toxin-antitoxin systems.

Dr Peter Cook, University of Manchester, Defining the key human innate immune cells that control anti-fungal immunity and inflammation.

Dr Laura Ferraiuolo, University of Sheffield, The involvement of exosomal RNA in astrocyte-mediated toxicity in motor neurone disease.

Dr Juan Fontana, University of Leeds, Elucidating the structure of previously inaccessible fusion intermediates of Influenza A Virus by cryo-electron microscopy.

Dr James Garnett, Queen Mary, University of London, A multidisciplinary approach to identify new antibacterial targets within biofilms.

Dr Katie Gillies, University of Aberdeen, Feedback matters: How should trial results be reported back to participants?

Dr Jamie Johnston, University of Leeds, Optical mapping of olfactory circuitry.

Dr Antreas Kalli, University of Leeds, Membrane transport proteins: Understanding the red cell Band 3 anion exchanger function.

Dr Peter Keating, University College London, Developmental impact of intermittent hearing loss on spatial hearing in noisy environments

Dr Tiziana Lembo, University of Glasgow, Understanding cultural, social and epidemiological drivers of human anthrax infection in rural African communities.

Dr David Llobet-Navas, Newcastle University, Control of somatic reprogramming by the microRNA cluster-424/503 during breast tumorigenesis and its relation with pregnancy.

Dr Christian Nielsen, Queen Mary University of London, Organic Bioelectronic Sensors for Epilepsy Diagnosis.

Dr Michael Okun, University of Leicester, How do individual neurons engage in resting-state infraslow dynamics of the cortex?

Dr Alice Pollitt, University of Reading, Impact of Podoplanin signalling complexes on the separation of the lymphatic and blood vasculatures in vivo.

Dr Andela Saric, University College London, Amyloid aggregation: Inhibition of self-replication and membrane-mediated control.

Dr Inez  Schoenmakers, University of East Anglia, Does vitamin D supplementation have anabolic effects on the osteocyte and does it benefit the renal-bone axis?

Dr Amanda Sferruzzi-Perri, University of Cambridge, Materno-fetal resource allocation; altering placental endocrine function by IGF2.

Dr Yihua Wang, University of Southampton, The role of Factor inhibiting HIF (FIH) in the development of idiopathic pulmonary fibrosis (IPF).

Dr Anna Barnard, Imperial College London, Selective Helix-Mimetics as Tools in Malaria Research.

Dr Christos Bergeles, University College London, 3D In-Focus Endoscopic Imaging with Light-Field Cameras: Optomechatronics and Algorithms.

Dr Maike Bublitz, University of Oxford, Proton Transporting ATPases: Structural and Functional Studies of Fungal Proton Pumps.

Dr Angus Cameron, Queen Mary University of London, Defining the role of PKN2 in cancer-associated fibroblasts.

Dr Richard Chahwan, University of Exeter, Chromatin modifications in genomic stability, immune diversity, and tumorigenesis.

Dr Edwin Chen, University of Leeds, Role of CHD4 Helicase in Malignant Megakaryopoiesis.

Dr Mihaela Crisan, University of Edinburgh, Investigate the link between the two hematopoietic stem cell types: different origins, different niches or both?

Dr Molly Crockett, University of Oxford, Identifying risk factors for personality disorder using computational neuroimaging and ecological momentary assessment.

Dr Margaret Cunningham, University of Strathclyde, A multi-disciplinary approach to thrombin receptor research – A focus on the interrogation of the Proteinase-activated Receptor 4 (PAR4) interactome.

Dr Alice Davidson, University College London, Investigating TCF4 triplet-repeat-mediated pathogenic mechanisms associated with Fuchs endothelial corneal dystrophy (FECD), a visually devastating and common age-related disease.

Dr Emma Dempster, University of Exeter, Using functional epigenomics to dissect the molecular architecture of schizophrenia.

Dr Catherine Hall, University of Sussex, How does Apolipoprotein E4 affect brain oxygenation and blood flow?

Dr Sian  Henson, Queen Mary University of London, Investigating the dynamics of senescent human T-cell trafficking.

Dr Daniel Horton, University of Surrey, Understanding constraints and drivers acting on viruses that cross species barriers, using rabies virus as a model.

Dr Benjamin Lehne, Imperial College London, A trans-ethnic gut microbiome study of insulin resistance.

Dr Florian Merkle, University of Cambridge, Regulation of human neurones that promote feeding

Dr Emily Noël,   University of Sheffield, The second heart field and cardiac morphogenesis – using transcriptomics to unravel heart development.

Dr Paulo Ribeiro, Queen Mary University of London, The Interplay Between Polarity and Hippo Signalling in the Regulation of Tissue Growth.

Dr Samantha Terry, King's College London, Radiobiological assessment of radionuclides used for therapy; how can they be used effectively?


The scheme is generously supported by the Wellcome Trust, British Heart Foundation , the Government Department for Business, Energy and Industrial Strategy, as part of the Global Challenges Research Fund and the Talent fund and Diabetes UK.

  BHF logo            

Staff leads

AMSlive launch at the 2018 Helix Group Reception

Book Now

Delivering novel therapies in the 21st century

Book Now

Clinical Academics in Training Annual Conference 2018

Book Now
View more
FB Twitter Instagram Youtube